MORNING UPDATE: Man Securities Inc. issues alerts for TWX, ERES, NUE, LIN, and BMC
March 14 2005 - 8:24AM
PR Newswire (US)
MORNING UPDATE: Man Securities Inc. issues alerts for TWX, ERES,
NUE, LIN, and BMC CHICAGO, March 14 /PRNewswire/ -- Man Securities
issues the following Morning Update at 8:30 AM EST with new
PriceWatch Alerts for key stocks. (Logo:
http://www.newscom.com/cgi-bin/prnh/20020214/MANSECLOGO ) Before
the open... PriceWatch Alerts for TWX, ERES, NUE, LIN, and BMC,
Market Overview, Today's Economic Calendar, and the Quote Of The
Day. QUOTE OF THE DAY "In general, rising interest rates are not
necessarily a bad thing for the market if they reflect a
strengthening economy, but if they reflect higher inflation, then
that could present a problem for the stock market." -- Michael
Sheldon, chief market strategist, Spencer Clarke. New PriceWatch
Alerts for TWX, ERES, NUE, LIN, and BMC... PRICEWATCH ALERTS - HIGH
RETURN COVERED CALL OPTIONS ----------- -- Time Warner Inc.
(NYSE:TWX) Last Price 17.50 - JUL 17.00 CALL OPTION@ $1.20 ->
4.3 % Return assigned* -- Eresearchtechnology Inc. (NASDAQ:ERES)
Last Price 11.53 - JUN 10.00 CALL OPTION@ $2.15 -> 6.6 % Return
assigned* -- Nucor Corp. (NYSE:NUE) Last Price 62.55 - JUL 55.00
CALL OPTION@ $10.30 -> 5.3 % Return assigned* -- Linens N Things
Inc. (NYSE:LIN) Last Price 22.65 - JUL 22.50 CALL OPTION@ $1.80
-> 7.9 % Return assigned* -- BMC Software Inc. (NYSE:BMC) Last
Price 15.83 - AUG 15.00 CALL OPTION@ $1.80 -> 6.9 % Return
assigned* * To learn more about how to use these alerts and for our
FREE report, "The 18 Warning Signs That Tell You When To Dump A
Stock ", go to: http://www.investorsobserver.com/mu18 (Note: You
may need to copy the link above into your browser then press the
[ENTER] key) ** For the FREE report, "Is Your Investment Portfolio
Disaster Proof? - Insights, Stocks, And Strategies." go to:
http://www.investorsobserver.com/FREEDP NOTE: All stocks and
options shown are examples only. These are not recommendations to
buy or sell any security. NEWS LEADERS AND LAGGARDS So far today,
Endo Pharmaceuticals, International Business Machines, and
Ascential Software lead the list of companies with the most news
stories while OfficeMax and Genworth Financial are showing a spike
in news. The Walt Disney Co., Marriott International, and Cemex SA
de CV have the highest srtIndex scores to top the list of companies
with positive news while American International Group and Alcatel
lead the list of companies with negative news reports. AutoZone has
popped up with a high positive news sraIndex score. For the FREE
article titled, "Earnings Season Decoded - An Essential 15 Point
Checklist For Finding Winning Stocks." go to:
http://www.wallstreetsecretsplus.com/go/freemu/ MARKET OVERVIEW
Overseas markets are looking strong, as 12 of the 15 that we track
are currently higher with the cumulative average return standing at
plus 0.140 percent. The Japanese government surprised investors by
revising its Gross Domestic Product (GDP) data for the
October-December period. After the revision, Japan's GDP showed
slight expansion instead of a slight narrowing. The new GDP grew
0.1 percent from the July-September quarter. Japan's economy grew
at an annualized expansion of 0.5 percent, the earlier report
showed a 0.5 percent decline. The surprising revision up was
attributed to revisions in inventories and government consumption.
This revised data still indicates that Japan was in a technical
recession for half of 2004. The April contract on sweet crude oil
fell $1.23 a barrel, a 2.3-percent drop in trading on Friday. This
morning, crude oil has continued its decline, dipping 30 cents to
$54.13 a barrel. Be prepared for the investing week ahead with
Bernie Schaeffer's FREE Monday Morning Outlook. For more details
and to sign up, go to: http://www.investorsobserver.com/freemo
DYNAMIC MARKET OPPORTUNITIES With a 7% increase in 2004, global
drug sales experienced the slowest year for growth since 1998. In
total, sales hit US$550 billion, with a massive 45% coming from
North America. The news comes as drug/biotech companies endure a
fierce amount of additional pressure from the Food & Drug
Administration following several high-profile drug catastrophes
such as Merck's painkiller Vioxx and Biogen and Elan's multiple
sclerosis drug Tysabri. In addition, a shortage of new drugs on the
market is hurting profit margins at some companies. Unsurprisingly,
China boasts the fastest-growing drug market, with sales soaring
28% last year to US$9.5 billion. The data comes courtesy of IMS
Health, which goes on to note that China will enjoy the fastest
growth rate for the next four years, with the compound annual
figure reaching 13%-16%. That's significantly higher than the rest
of the world, which will muster up 6% to 9% drug sales growth. The
world's biggest-selling drug in 2004 was Pfizer's cholesterol drug
Lipitor, which posted global sales of US$12 billion last year.
Merck's cholesterol drug Zocor finished second, with US$5.9 billion
in sales, while Bristol-Myers Squibb's anti-clotting product Plavix
ended third, with sales of US$5 billion. While drug sales slowed,
one area that experienced solid growth was advertising spending.
The U.S. presidential and Summer Olympics contributed to spending
rising almost 10% in 2004 - the best year since 2000 - as the total
amount spent hit US$141.1 billion. TNS Media Intelligence reports
that of 17 subsectors, 16 enjoyed increases last year, with only
national spot radio ads seeing a decline. Online ad spending was
the biggest gainer, with a 20% spike. By company, General Motors
boosted its advertising with a massive 17.5% increase to US$2.8
billion. But Proctor & Gamble took the honors for greatest
amount spent with a 7.4% rise to US$2.9 billion. Receive incisive
economic/market commentary, profitable advice and access to a
network of leading investment exports. Simply follow this link:
http://www.investorsobserver.com/agora2 TODAY'S ECONOMIC CALENDAR
No major economic news today. Actively track stocks with
Quote.com's QCharts and get the real time quotes and streaming
technical charts you need to keep up with the market. For your free
30-day trial go to: http://www.investorsobserver.com/MUQuote1 Man
Securities Inc. is one of the world's leading option order
execution firms. Man's in-house broker team offers a level of
personal service and experience unavailable from no-frills discount
brokers. To improve your understanding of option pricing get Man's
FREE "Margin/Option Wizard software at:
http://www.investorsobserver.com/mancd. Member CBOE/NASD/SPIC. CRD#
6731 This Morning Update was prepared with data and information
provided by: InvestorsObserver.com - Better Strategies for Making
Money -> For Investors With a Sense of Humor. Only $1 for your
first month plus seven free bonuses worth over $420, see:
http://www.investorsobserver.com/must Quote.com QCharts- Real time
quotes and streaming technical charts to keep you up with the
market. Analyze, predict, and stay ahead. for a Free 30 day trial
go to: http://www.investorsobserver.com/MUQuote2 247profits.com:
You'll get exclusive financial commentary, access to a global
network of experts and undiscovered stock alerts. Register NOW for
the FREE 247profits e-Dispatch. Go to:
http://www.investorsobserver.com/agora Schaeffer's Investment
Research - Sign up for your FREE e-weekly, Monday Morning Outlook,
Bernie Schaeffer's look ahead at the markets. Sign Up Now
http://www.investorsobserver.com/freemo PowerOptionsPlus - The Best
Way To Find, Compare, Analyze, and Make Money On Options
Investments. For a 14-Day FREE trial and 5 FREE bonuses go to:
http://www.investorsobserver.com/poweropt All stocks and options
shown are examples only. These are not recommendations to buy or
sell any security and they do not represent in any way a positive
or negative outlook for any security. Potential returns do not take
into account your trade size, brokerage commissions or taxes which
will affect actual investment returns. Stocks and options involve
risk and are not suitable for all investors and investing in
options carries substantial risk. Prior to buying or selling
options, a person must receive a copy of Characteristics and Risks
of Standardized Options available from Sharon at 800-837-6212 or at
http://www.cboe.com/Resources/Intro.asp. Privacy policy available
upon request.
http://www.newscom.com/cgi-bin/prnh/20020214/MANSECLOGO
http://photoarchive.ap.org/ DATASOURCE: Man Securities CONTACT:
John Gannon of Man Securities Inc., +1-800-837-6212 Web site:
http://www.mansecurities.com/mu.html
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024